Neumora Therapeutics, Inc. (NMRA) Discusses Positive Phase 1b Results for NMRA-511 in Alzheimer's Disease Agitation Transcript
Source: SeekingAlpha
2026-01-05 13:28:01 ET
Neumora Therapeutics, Inc. (NMRA) Discusses Positive Phase 1b Results for NMRA-511 in Alzheimer's Disease Agitation January 5, 2026 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Neumora Therapeutics, Inc. (NMRA) Discusses Positive Phase 1b Results for NMRA-511 in Alzheimer's Disease Agitation Transcript
Neumora Therapeutics Inc.
NASDAQ: NMRA
NMRA Trading
0.0% G/L:
$3.545 Last:
221,326 Volume:
$3.50 Open:
NMRA Latest News
February 04, 2026 07:00:00 am
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
January 05, 2026 06:35:00 am
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones
NMRA Stock Data
$499,596,451
52,800,160
10.86%
30
N/A
Biotechnology & Life Sciences
Healthcare
US
Watertown
